TranslationalAdvances in theField ofPulmonaryHypertension.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs-Reference-Cited by-同舟云学术

TranslationalAdvances in theField ofPulmonaryHypertension.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs

Published:2017-02-15 Issue:4 Volume:195 Page:425-437
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Pullamsetti Soni Savai¹²³,Savai Rajkumar¹²³,Seeger Werner¹²³,Goncharova Elena A.⁴

Affiliation:

1. Department of Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, member of the German Center for Lung Research (DZL), Bad Nauheim, Germany

2. Department of Internal Medicine, Universities of Giessen and Marburg Lung Center, member of the DZL, Giessen, Germany

3. Justus Liebig University, Giessen, Germany; and

4. Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference131 articles.

1. Pathogenesis of pulmonary arterial hypertension: lessons from cancer

2. Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities

3. The Cancer Paradigm of Severe Pulmonary Arterial Hypertension

4. Primary Pulmonary Hypertension Between Inflammation and Cancer

5. The Right Ventricle in Pulmonary Arterial Hypertension

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOX9 promotes hypoxic pulmonary hypertension through stabilization of DPP4 in pulmonary artery smooth muscle cells;Experimental Cell Research;2024-10

2. Unraveling the Mfn2-Warburg effect nexus: a therapeutic strategy to combat pulmonary arterial hypertension arising from catch-up growth after IUGR;Respiratory Research;2024-09-02

3. PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-09-01

4. DGP-Kongress 2024 – „Key Takeaways aus Keynote Lectures“: Pneumologie erblühe: selbstbewusst, zukunftsorientiert und präventiv orientiert;Pneumologie;2024-08-05

5. Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancer;BMJ Open Respiratory Research;2024-08